BEHRENS M KATHLEEN bought SRPT

January 27, 2026 · Form 4 insider transaction

BEHRENS M KATHLEEN bought 10,500 shares of Sarepta Therapeutics, Inc. at $13.71 per share, a transaction worth $144.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.